Search Results - "Lazzeroni, M"

treatment outcome prediction from modeling the clinical target distribution for high-grade gliomas by Hager, W., Lazzeroni, M., Astaraki, Mehdi, Toma-Dasu, I.

Get full text

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast by Pruneri, G., Lazzeroni, M., Bagnardi, V., Tiburzio, G.B., Rotmensz, N., DeCensi, A., Guerrieri-Gonzaga, A., Vingiani, A., Curigliano, G., Zurrida, S., Bassi, F., Salgado, R., Van den Eynden, G., Loi, S., Denkert, C., Bonanni, B., Viale, G.

“…Tumor-infiltrating lymphocytes (TILs) are a robust prognostic adjunct in invasive breast cancer, but their clinical role in ductal carcinoma in situ (DCIS) has…”
Get full text

diffusion model based target definition for high-grade gliomas: robustness analysis by Hager, W., Lazzeroni, M., Astaraki, Mehdi, Toma-Dasu, I.

Get full text

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis by Gandini, S., Lazzeroni, M., Peccatori, F.A., Bendinelli, B., Saieva, C., Palli, D., Masala, G., Caini, S.

“…We conducted a meta-analysis of studies reporting on the risk of extra-ovarian malignancies among women with endometriosis. Summary relative risk (SRR) and 95%…”
Get full text

The effect of metformin on apoptosis in a breast cancer presurgical trial by Cazzaniga, M, DeCensi, A, Pruneri, G, Puntoni, M, Bottiglieri, L, Varricchio, C, Guerrieri-Gonzaga, A, Gentilini, O D, Pagani, G, Dell'Orto, P, Lazzeroni, M, Serrano, D, Viale, G, Bonanni, B

“…Background: Metformin has been associated with antitumour activity in breast cancer (BC) but its mechanism remains unclear. We determined whether metformin…”
Get full text

Model based target definition for high-grade gliomas: implementation and sensitivity analysis by Hager, W., Lazzeroni, M., Astaraki, Mehdi, Toma-Dasu, I.

Get full text

Acceptability of chemoprevention trials in high-risk subjects by Bonanni, B, Lazzeroni, M

“…The development and current widespread acceptance of clinical trials is one of the major conceptual advances in research medicine introduced during the second…”
Get full text

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ by Curigliano, G, Disalvatore, D, Esposito, A, Pruneri, G, Lazzeroni, M, Guerrieri-Gonzaga, A, Luini, A, Orecchia, R, Goldhirsch, A, Rotmensz, N, Bonanni, B, Viale, G

“…To assess the prognostic role of human epidermal growth factor receptor 2 (HER2) overexpression in patients with ductal carcinoma in situ (DCIS). We identified…”
Get full text

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype by Lazzeroni, M, Guerrieri-Gonzaga, A, Botteri, E, Leonardi, M C, Rotmensz, N, Serrano, D, Varricchio, C, Disalvatore, D, Castillo, A Del, Bassi, F, Pagani, G, DeCensi, A, Viale, G, Bonanni, B, Pruneri, G

“…Background: The post-surgical management of ductal intraepithelial neoplasia (DIN) of the breast is still a dilemma. Ki-67 labelling index (LI) has been…”
Get full text

Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting by Lazzeroni, M., Ureba, A., Rosenberg, V., Schäfer, H., Rühle, A., Baltas, D., Toma-Dasu, I., Grosu, A.L.

“…•Rigid/deformable image registrations of FMISO-PET/CT to planning CT were compared.•The registration impacts on localisation and morphology of the hypoxic…”
Get full text

OC-0271: Production of high quality 11C beams for radiation therapy and PET-CT dose delivery verification by Lazzeroni, M, Brahme, A

Get full text

Influence of tumor infiltration on treatment outcome in Gamma Knife Radiosurgery: a modeling study by Lazzeroni, M., Khazraei Manesh, Zohreh, Sandstrom, H., Barsoum, P., Toma-Dasu, I.

Get full text

Production of clinically useful positron emitter beams during carbon ion deceleration by Lazzeroni, M, Brahme, A

“…In external beam radiation therapy, radioactive beams offer the best clinical solution to simultaneously treat and in vivo monitor the dose delivery and tumor…”
Get more information

Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region by Lazzeroni, M, Toma-Dasu, I, Ureba, A, Schiavo, F, Wiedenmann, N, Bunea, H, Thomann, B, Baltas, D, Mix, M, Stoykow, C, Sörensen, A, Grosu, A L

“…Tumor hypoxia may play a fundamental role in determining the radiotherapy outcome for several cancer types. Functional imaging with hypoxia specific…”
Get more information

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials by Gandini, S., Guerrieri-Gonzaga, A., Pruneri, G., Serrano, D., Cazzaniga, M., Lazzeroni, M., Veronesi, P., Johansson, H., Bonanni, B., Viale, G., DeCensi, A.

“…Ki-67 is increasingly being used as a response biomarker in window of opportunity, pre-surgical trials for breast cancer patients. Since Ki-67 is often higher…”
Get full text

Long-term effects of inhaled budesonide on screening-detected lung nodules by Veronesi, G., Lazzeroni, M., Szabo, E., Brown, P.H., DeCensi, A., Guerrieri-Gonzaga, A., Bellomi, M., Radice, D., Grimaldi, M.C., Spaggiari, L., Bonanni, B.

“…We evaluated the long-term outcomes of a randomized, double-blind, placebo-controlled phase IIb trial of inhaled budesonide in 202 current and former smokers…”
Get full text

EP-1874: Effective radiosensitivity maps of early tumour responsiveness based on repeated FDG PET scans by Lazzeroni, M, Uhrdin, J, Sonke, J.J, Hamming-Vrieze, O, Dasu, A, Toma-Dasu, I

Get full text

24 11C POSITRON EMITTER BEAMS PRODUCED BY 12C PROJECTILE FRAGMENTATION FOR IMPROVED ACCURACY IN DOSE DELIVERY VERIFICATION by Lazzeroni, M, Brahme, A

Get full text

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial by Serrano, D, Lazzeroni, M, Zambon, C-F, Macis, D, Maisonneuve, P, Johansson, H, Guerrieri-Gonzaga, A, Plebani, M, Basso, D, Gjerde, J, Mellgren, G, Rotmensz, N, Decensi, A, Bonanni, B

“…The role of pharmacogenomics and tamoxifen was investigated by analyzing several polymorphisms of cytochrome P450 and SULT1A1 gene in a nested case control…”
Get full text

Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients by Lazzeroni, M., Uhrdin, J., Carvalho, S., van Elmpt, W., Lambin, P., Dasu, A., Wersäll, P., Toma-Dasu, I.

“…•Predictive power of repeated PET images for NSCLC overall survival was investigated.•PET images were acquired before treatment and during the third week.•SUV…”
Get full text